CN117185456A - Method for removing kanamycin by utilizing abiotic humification - Google Patents

Method for removing kanamycin by utilizing abiotic humification Download PDF

Info

Publication number
CN117185456A
CN117185456A CN202311177638.8A CN202311177638A CN117185456A CN 117185456 A CN117185456 A CN 117185456A CN 202311177638 A CN202311177638 A CN 202311177638A CN 117185456 A CN117185456 A CN 117185456A
Authority
CN
China
Prior art keywords
kanamycin
waste
tea polyphenol
remover
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202311177638.8A
Other languages
Chinese (zh)
Other versions
CN117185456B (en
Inventor
刘惠玲
惠雪松
王艳琼
戴晓虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tongji University
Original Assignee
Tongji University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tongji University filed Critical Tongji University
Priority to CN202311177638.8A priority Critical patent/CN117185456B/en
Publication of CN117185456A publication Critical patent/CN117185456A/en
Application granted granted Critical
Publication of CN117185456B publication Critical patent/CN117185456B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a method for removing kanamycin by utilizing abiotic humification, which belongs to the technical field of antibiotic waste innocent treatment, and comprises the steps of adding a remover and a catalyst into kanamycin waste, and adjusting pH to be alkaline for reaction; the remover comprises tea polyphenol, and the catalyst comprises MnO 2 . The method can achieve the highest removal rate of more than 99.0% for kanamycin in the kanamycin fermentation wastewater and kanamycin fermentation fungus residues, reduces the decomposition of organic matters in the waste treatment process, and is more environment-friendly; more nutrient components such as amino acid, protein and the like in the waste can be reserved in the treatment process, so that the subsequent recycling is facilitated; the tea polyphenol source can be wastewater rich in tea polyphenol, so that waste treatment with waste is expected to be realized; in conclusion, the method has low requirements on operation and equipment and good treatment effect, and is a clean and sustainable kanamycin removal methodIs a novel method of (a).

Description

Method for removing kanamycin by utilizing abiotic humification
Technical Field
The invention relates to the technical field of innocent treatment of antibiotic wastes, in particular to a method for removing kanamycin by utilizing abiotic humification.
Background
Kanamycin is a typical aminoglycoside antibiotic and is an important drug for treating serious infection of aerobic gram-negative bacillus. As with other antibiotics, kanamycin is accompanied by contamination during production and use of kanamycin. Especially, the pharmaceutical wastes (including fermentation wastewater and fermentation fungus residues) of kanamycin are directly discharged into the environment without being effectively treated, so that on one hand, kanamycin in the wastes possibly enters the human body through a food chain to influence the health of the human body, and on the other hand, kanamycin in the environment can form selective pressure on environmental microorganisms so as to screen or promote the growth of drug-resistant bacteria, thereby bringing potential safety hazards to human society. Therefore, the treatment of kanamycin in waste is of great importance.
Traditional waste treatment methods include incineration, physical and chemical treatment or microbiological treatment. For organic-resistant wastes, pretreatment is generally adopted to primarily remove antibiotic residues for recycling, including anaerobic digestion or composting, wherein the mainstream pretreatment methods include thermal hydrolysis and advanced oxidation processes, which can effectively remove antibiotics in the wastes, but high equipment, energy input or medicament cost increase the burden of treating the wastes of related enterprises; in addition, during the treatment, other organic matters can be oxidized and decomposed, and the processes are often accompanied with CO 2 Or NO x Thereby causing new environmental problems.
Disclosure of Invention
The invention aims to provide a method for removing kanamycin by utilizing abiotic humification, which solves the problems in the prior art, can efficiently remove kanamycin content in fermentation wastewater and fermentation fungus residues, has low requirements on operation and equipment and good treatment effect, and provides a novel method for removing kanamycin in clean and sustainable waste.
In order to achieve the above object, the present invention provides the following solutions:
the invention provides a method for removing kanamycin by utilizing abiotic humification, which comprises the following steps:
adding a remover and a catalyst into kanamycin waste, and adjusting the pH value to be alkaline for reaction;
the remover comprises tea polyphenol, and the catalyst comprises MnO 2
Further, the tea polyphenol is used in an amount of 1.5 to 10 times the mass of kanamycin, and the MnO 2 The amount of (B) is 0.01-0.5 times of kanamycin.
Further, the pH is adjusted to be alkaline by using a hydroxide solution of an alkali metal or an alkaline earth metal.
Further, the pH was adjusted to be alkaline with NaOH solution.
Further, the pH is adjusted to 8.5-9.0.
Further, the reaction conditions include: stirring at 25-80deg.C for 1-48 hr.
Further, the stirring speed is 400-800rpm.
Further, the waste includes fermentation wastewater and fermentation residues.
Further, the method further comprises the step of adjusting the water content of the zymophyte residue containing kanamycin to 85-95% before adding the remover and the catalyst.
The invention discloses the following technical effects:
the method is adopted to remove kanamycin, and experimental results show that the highest removal rate of kanamycin in the kanamycin fermentation wastewater and kanamycin fermentation residues can reach more than 99.0%. Compared with the traditional pollutant treatment processes, such as thermal hydrolysis and advanced oxidation processes, the method for removing kanamycin from waste by utilizing abiotic humification reduces the decomposition of organic matters in the process of treating the waste, thus CO 2 The emission of the equal gas is less, and the environment is more friendly; the method can be carried out in a normal temperature environment, so that the heat cost and the like are low; the method has lower technical requirements on the reactor, and more nutrient components in the waste, such as amino acid, protein and the like, can be reserved in the treatment process, so that the method is beneficial to subsequent recycling; in addition, the tea polyphenol source can be wastewater rich in tea polyphenol, so that waste treatment with waste is expected to be realized. In summary, the treatment method has low operation and equipment requirements and good treatment effect, and is a novel method for removing kanamycin from clean and sustainable waste.
Detailed Description
Various exemplary embodiments of the invention will now be described in detail, which should not be considered as limiting the invention, but rather as more detailed descriptions of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. In addition, for numerical ranges in this disclosure, it is understood that each intermediate value between the upper and lower limits of the ranges is also specifically disclosed. Every smaller range between any stated value or stated range, and any other stated value or intermediate value within the stated range, is also encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the invention described herein without departing from the scope or spirit of the invention. Other embodiments will be apparent to those skilled in the art from consideration of the specification of the present invention. The specification and examples of the present invention are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are intended to be inclusive and mean an inclusion, but not limited to.
The tea polyphenol (CAS number: 84650-60-2) used in the invention is purchased from Shanghai Michlin Biochemical technology Co., ltd, the purity is 99%, and the product number is T821916; catalyst MnO 2 (CAS number 1313-13-9) available from Shanghai Taitan technologies Co., ltd., purity of 99.9%, cat number 014279804; other reagents are all routinely commercially available.
The technical principle of the invention is as follows:
in alkaline environment, polyphenols pass through MnO 2 Can be converted into quinone substances after catalysis. According to the theory of polyphenols formed by humus, primary amine groups of organic substances (e.g., amino acids, etc.) can undergo nucleophilic reaction with quinone substances to form complex macromolecular humic acid substances. In the method for removing kanamycin in waste by using abiotic humification in the following example, kanamycin has 4 primary amine groups, can be used as an ideal primary amine donor in the abiotic humification process, and tea polyphenol is used as a polyphenol donor, and abiotic humification reaction occurs between the two primary amine groups, so that kanamycin finally becomes a part of macromolecular humic acid substances, and further removal of kanamycin in waste is realized. The specific embodiment is as follows:
example 1
Adding tea polyphenol solution into kanamycin standard solution (kanamycin concentration is 1000 mg/L) to make final concentration of tea polyphenol in kanamycin standard solution be 2000mg/L; adding MnO 2 To MnO 2 The final concentration in the wastewater is 100mg/L; adding NaOH solution to adjust the pH of the solution = 9; the mixture was placed on a thermostatic shaker at 25℃and shaken at 180rpm for 24h.
Example 2
The only difference from example 1 is that the system ph=7 and the reaction time is 48h.
Example 3
The difference from example 1 was only that the reaction temperature was 50℃and the reaction time was 3 hours.
Example 4
As in example 1, the only difference is MnO 2 The addition amount is 0, the reaction temperature is 50 ℃, and the reaction time is 3 hours.
Example 5
Adding tea polyphenol solution into kanamycin fermentation wastewater (kanamycin content is 200 mg/L) to make final concentration of tea polyphenol in wastewater be500mg/L; adding MnO 2 To make MnO in the wastewater 2 The final concentration is 100mg/L; adding NaOH solution to ensure that the pH value of the wastewater is=9; the wastewater was placed on a thermostatic shaker at 25℃and shaken at 180rpm for 24h.
Example 6
Adding water into kanamycin fermentation bacteria residues to adjust the water content of a reaction system to 85%, wherein the kanamycin content in the system is 2000mg/kg, and then adding a tea polyphenol solution to enable the final concentration of tea polyphenol in the reaction system to be 20000mg/kg; adding MnO 2 So that MnO in the fungus residue 2 The final dose of (2) is 1000mg/kg; adding NaOH solution so that the final pH of the reaction system was=9; the reaction system was placed on a thermostatic shaker at 25℃and shaken at 180rpm for 48h.
Example 7
The only difference from example 6 is that the final dose of tea polyphenols in the system was 4000mg/kg, the reaction temperature was 80℃and the reaction time was 6 hours.
Example 8
As in example 6, the difference is only MnO in the system 2 The final dosage of (2) is 1000mg/kg, the final concentration of tea polyphenol in the system is 6000mg/kg, the reaction temperature is 80 ℃, and the reaction time is 6h.
Effect verification
Kanamycin was detected by liquid chromatography, briefly as follows: kanamycin was quantified using a Diode Array Detector (DAD) with o-phthalaldehyde (OPA) as derivatizing reagent. The preparation conditions of the derivatization reagent are as follows: 200mg of phthalic dicarboxaldehyde is dissolved in 40mL of methanol, 800 mu L of triethylamine and 200 mu L of 2-mercaptoethanol are added, and the derivatization reagent can be stored for 7 days at the temperature of minus 20 ℃; the derivatization steps are as follows: the filtered sample and 0.5mL of derivatizing reagent were transferred to LC injection vials and thoroughly mixed. Derivatization was performed in a dark environment at 25 ℃ for 15 minutes, and then the derivatized product was injected into the LC system. Notably, the hydrophobicity of the derivative product requires the use of a non-plastic centrifuge tube as the derivative vessel in this study. In addition, OPA derivatives have poor stability and require tight control of derivatization time for each sample prior to sample introduction and analysis; liquid chromatography parameters: quantification of the derived products was performed using a 1200 series high performance liquid chromatography system (Agilent technologies, inc. of Santa Clara, calif., USA). A Zorbax Eclipse XDB C column (150X 4.6mm,5.0 μm) from Agilent technologies, inc. of Santa Clara, calif. was used. The mobile phase was 1% triethylamine solution (ph=8.2-8.5, adjusted with formic acid) as mobile phase a, mobile phase B was methanol, flow rate was 1.5mL/min, gradient composition was 25% a and 75% B, total run time per sample was 10min. The detection wavelength of DAD was 341nm. The test results of kanamycin removal by the method of examples 1 to 8 are shown in Table 1:
TABLE 1
Kanamycin removal rate (%)
Example 1 99.4
Example 2 85.3
Example 3 99.6
Example 4 92.3
Example 5 99.4
Example 6 98.9
Example 7 97.4
Example 8 99.2
From the data in Table 1, it can be seen that tea polyphenols were used as polyphenol donors and kanamycin was significantly removed from the system by abiotic humification. Example 4 shows that MnO 2 The progress of the reaction can be promoted; examples 1, 2, 3 show that the reaction needs to be carried out under alkaline conditions; example 5 shows that kanamycin can be effectively removed in a wastewater system; example 7 shows that tea polyphenol dose is a critical factor in order to achieve higher kanamycin removal efficiency in real waste; examples 6 and 8 show that there is a higher kanamycin removal rate at 80 c because tea polyphenols or kanamycin can be adsorbed by impurities in the waste, thus reducing the reaction efficiency and facilitating its desorption at higher temperatures. Even so, the removal rate of kanamycin in the bacterial residues can still be realized at 25 DEG C>98%。
The above embodiments are only illustrative of the preferred embodiments of the present invention and are not intended to limit the scope of the present invention, and various modifications and improvements made by those skilled in the art to the technical solutions of the present invention should fall within the protection scope defined by the claims of the present invention without departing from the design spirit of the present invention.

Claims (9)

1. A method for removing kanamycin by using abiotic humification, which comprises the following steps:
adding a remover and a catalyst into wastes containing kanamycin, and adjusting the pH value to be alkaline for reaction;
the remover comprises tea polyphenol, and the catalyst comprises MnO 2
2. The method according to claim 1, characterized in thatCharacterized in that the dosage of the tea polyphenol is 1.5-10 times of the mass of kanamycin, and the MnO 2 The amount of (B) is 0.01-0.5 times of kanamycin.
3. The method according to claim 1, wherein the pH is adjusted to alkaline with an alkali or alkaline earth metal hydroxide solution.
4. A method according to claim 3, characterized in that the pH is adjusted to alkaline with NaOH solution.
5. The method of claim 4, wherein the pH is adjusted to 8.5-9.0.
6. The method of claim 1, wherein the reaction conditions comprise: stirring at 25-80deg.C for 1-48 hr.
7. The method of claim 6, wherein the stirring is at a rate of 400-800rpm.
8. The method of claim 1, wherein the waste comprises fermentation wastewater and fermentation sludge.
9. The method according to claim 8, further comprising the step of adjusting the moisture content of the fermentation residue containing kanamycin to 85-95% before adding the remover and the catalyst.
CN202311177638.8A 2023-09-13 2023-09-13 Method for removing kanamycin by utilizing abiotic humification Active CN117185456B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311177638.8A CN117185456B (en) 2023-09-13 2023-09-13 Method for removing kanamycin by utilizing abiotic humification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311177638.8A CN117185456B (en) 2023-09-13 2023-09-13 Method for removing kanamycin by utilizing abiotic humification

Publications (2)

Publication Number Publication Date
CN117185456A true CN117185456A (en) 2023-12-08
CN117185456B CN117185456B (en) 2024-04-12

Family

ID=88984622

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311177638.8A Active CN117185456B (en) 2023-09-13 2023-09-13 Method for removing kanamycin by utilizing abiotic humification

Country Status (1)

Country Link
CN (1) CN117185456B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB891534A (en) * 1957-12-16 1962-03-14 Hamao Umezawa Kanamycin b and its isolation from a fermentation broth
JPS52153942A (en) * 1976-06-16 1977-12-21 Microbial Chem Res Found Preparation of kanamicin c deoxy derivatives and kanamicine c or its deoxy derivatives
CN1476459A (en) * 2000-11-30 2004-02-18 ����贻�ѧ��ҵ��ʽ���� Aliphatic polyester copolymer and process for producing same, biodegradable resin molding based on aliphatic polyester, and lactone-containing resin
JP2013220398A (en) * 2012-04-18 2013-10-28 Hitachi Zosen Corp Method for suppressing bacteria proliferation in ethanol fermentation of kitchen waste
CN104342470A (en) * 2014-10-09 2015-02-11 福建师范大学 Harmless treatment method of Kanamycin residues and application of Kanamycin residues in preparation of Kanamycin
CN113003736A (en) * 2021-04-06 2021-06-22 安徽农业大学 Method for humification of phenol pollutants driven by fungal laccase and application
CN116078797A (en) * 2022-11-24 2023-05-09 同济大学 Method for recycling biogas residues

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB891534A (en) * 1957-12-16 1962-03-14 Hamao Umezawa Kanamycin b and its isolation from a fermentation broth
JPS52153942A (en) * 1976-06-16 1977-12-21 Microbial Chem Res Found Preparation of kanamicin c deoxy derivatives and kanamicine c or its deoxy derivatives
CN1476459A (en) * 2000-11-30 2004-02-18 ����贻�ѧ��ҵ��ʽ���� Aliphatic polyester copolymer and process for producing same, biodegradable resin molding based on aliphatic polyester, and lactone-containing resin
JP2013220398A (en) * 2012-04-18 2013-10-28 Hitachi Zosen Corp Method for suppressing bacteria proliferation in ethanol fermentation of kitchen waste
CN104342470A (en) * 2014-10-09 2015-02-11 福建师范大学 Harmless treatment method of Kanamycin residues and application of Kanamycin residues in preparation of Kanamycin
CN113003736A (en) * 2021-04-06 2021-06-22 安徽农业大学 Method for humification of phenol pollutants driven by fungal laccase and application
CN116078797A (en) * 2022-11-24 2023-05-09 同济大学 Method for recycling biogas residues

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JUAN LI ET AL: "Oxidative transformation of emerging organic contaminants by aqueous permanganate: Kinetics, products, toxicity changes, and effects of manganese products", 《WATER RESEARCH》, vol. 203, 2 August 2021 (2021-08-02), pages 117513, XP086771055, DOI: 10.1016/j.watres.2021.117513 *
XUESONG HUI ET AL.: "Overlooked abiotic humification for kanamycin removal in kanamycin fermentation waste by tea polyphenols: New, environmentally friendly and specific", 《CHEMICAL ENGINEERING JOURNAL》, vol. 478, 14 November 2023 (2023-11-14), pages 147377 *
李媛: "锰氧化物对有机污染物的转化机制研究进展", 《环境化学》, vol. 32, no. 7, 31 July 2013 (2013-07-31), pages 1288 - 1299 *
胡梦娜: "9-羟基雄烯二酮药物菌渣好氧堆肥无害化及安全利用", 《农业环境科学学报》, vol. 42, no. 9, 30 September 2023 (2023-09-30), pages 2096 - 2107 *

Also Published As

Publication number Publication date
CN117185456B (en) 2024-04-12

Similar Documents

Publication Publication Date Title
Zhi et al. Systematic analysis of occurrence and variation tendency about 58 typical veterinary antibiotics during animal wastewater disposal processes in Tianjin, China
Usman et al. Molecular and microbial insights towards understanding the anaerobic digestion of the wastewater from hydrothermal liquefaction of sewage sludge facilitated by granular activated carbon (GAC)
Zhang et al. Effect of the addition of exogenous precursors on humic substance formation during composting
Poirier et al. Improving anaerobic digestion with support media: Mitigation of ammonia inhibition and effect on microbial communities
Xia et al. Effects of tetracycline residuals on humification, microbial profile and antibiotic resistance genes during vermicomposting of dewatered sludge
Wang et al. Anaerobic biodegradation of four sulfanilamide antibiotics: kinetics, pathways and microbiological studies
Chen et al. Influence of roxithromycin as antibiotic residue on volatile fatty acids recovery in anaerobic fermentation of waste activated sludge
Wang et al. Effects of chlortetracycline, Cu and their combination on the performance and microbial community dynamics in swine manure anaerobic digestion
Wang et al. Acidic hydrothermal treatment: Characteristics of organic, nitrogen and phosphorus releasing and process optimization on lincomycin removal from lincomycin mycelial residues
Wang et al. Development of a compound microbial agent beneficial to the composting of Chinese medicinal herbal residues
Wang et al. Insight into the evolution of antibiotic resistance genes and microbial community during spiramycin fermentation residue composting process after thermally activated peroxydisulfate pretreatment
Ke et al. Component analysis and risk assessment of biogas slurry from biogas plants
CN112408685A (en) Method for removing residual antibiotics in antibiotic dreg slurry
CN108642092B (en) Method for enhancing anaerobic degradation of antibiotics
CN111807623A (en) Method for preparing composite carbon source for sewage treatment denitrification by using agricultural products
Ren et al. Safety of composts consisting of hydrothermally treated penicillin fermentation residue: Degradation products, antibiotic resistance genes and bacterial diversity
CN107337497A (en) A kind of method that organic fertilizer is produced using aminoglycoside antibiotics bacteria residue
Yang et al. Mechanism analysis of humification coupling metabolic pathways based on cow dung composting with ionic liquids
Zhang et al. Enhanced degradation of glucocorticoids, a potential COVID-19 remedy, by co-fermentation of waste activated sludge and animal manure: The role of manure type and degradation mechanism
Sertillanges et al. Process type is the key driver of the fate of organic micropollutants during industrial scale treatment of organic wastes
CN117185456B (en) Method for removing kanamycin by utilizing abiotic humification
Zhang et al. The efficiency of integrated wastewater treatment plant for pollutant removal from industrial-scale lincomycin production
Zhu et al. Biodegradation and potential effect of ranitidine during aerobic composting of human feces
Liu et al. Treatment of sewage sludge hydrothermal carbonization aqueous phase by Fe (II)/CaO2 system: Oxidation behaviors and mechanism of organic compounds
Penaud et al. Influence of thermochemical pretreatment conditions on solubilization and anaerobic biodegradability of a microbial biomass

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant